Status:
COMPLETED
Alterations of Muscle Secretome Associated With Muscle Atrophy Caused by Glucocorticoids
Lead Sponsor:
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Conditions:
Cushing Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Several studies have shown that lean mass, in particular muscle mass, is an excellent predictive survival factor in many diseases. A better knowledge of the mechanisms responsible for muscle atrophy a...
Eligibility Criteria
Inclusion
- Pituitary or adrenal endogenous Cushing's syndrome formally demonstrated by the standard endocrinological assessment
- New diagnosis or recurrence or persistent Cushing's syndrome after pituitary surgery
Exclusion
- Pseudo Cushing's syndrome
- Paraneoplasic Cushing's syndrome
- Cyclic Cushing's syndrome
- Adrenocortical carcinoma
- Pituitary irradiation during the last six months
Key Trial Info
Start Date :
January 2 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 18 2017
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03229395
Start Date
January 2 2014
End Date
July 18 2017
Last Update
July 25 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
De Barsy Marie
Brussels, Belgium, 1200